Wednesday, June 24, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analyst Expresses Optimism for Lam Researchs Future Prospects

Elaine Mendonca by Elaine Mendonca
January 27, 2024
in Breaking News
0
Biotechnology Market Capitalization
0
SHARES
12
VIEWS
Share on FacebookShare on Twitter

On January 27, 2024, Toshiya Hari, an analyst at Goldman Sachs, expressed optimism about the future prospects of Lam Research (NASDAQ:LRCX). Hari maintained a Buy rating on the company’s stock and increased the price target from $700 to $912. This upward adjustment signifies a positive outlook on the stock, suggesting the anticipation of a higher future stock price.

Notably, various other analyst firms have also provided their price targets for Lam Research. The highest price target stands at $980, while the lowest is at $655. This range of expectations within the market showcases the diverse perspectives on the company’s potential.

Over the past year, a consensus has emerged among 22 analysts’ ratings, indicating a Moderate Buy sentiment. On average, these analysts predict a twelve-month price of $778.05, with the highest price target aligning with Hari’s revised target at $912.

Lam Research Corporation (LRCX) Stock Performance Declines: Factors and Analysis for Investors

On January 27, 2024, Lam Research Corporation (LRCX) experienced a decline in its stock performance. According to data from CNN Money, the price of LRCX shares decreased by $26.56 since the market last closed, representing a 3.07% drop. The stock closed at $839.04, which was already a significant decrease from its previous value. Furthermore, in after-hours trading, the stock dropped an additional $0.04. The decrease in LRCX’s stock price could be attributed to various factors, including a broader market downturn and negative news or developments related to Lam Research Corporation. Investors should conduct thorough research and analysis before making any investment decisions.

Lam Research Corporation (LRCX) Shows Stable Performance and Positive Growth in Key Financial Metrics on January 27, 2024

Lam Research Corporation (LRCX) has shown stable performance in its stock on January 27, 2024. The company’s total revenue for the past year was $17.43 billion, with $3.76 billion in the second quarter. LRCX’s total revenue has remained flat since the previous year, but there has been a 7.93% growth since the last quarter, indicating recent improvement in financial performance. Net income for the past year was $4.51 billion, with $954.27 million in the second quarter. Net income has remained stable since the previous year, but there has been a 7.54% increase since the last quarter, suggesting improved profitability. Earnings per share (EPS) for the past year was $33.21, increasing to $7.22 in the second quarter. EPS has remained flat since the previous year, but there has been an 8.35% growth since the last quarter, indicating improved profitability per share. Overall, LRCX’s stock performances on January 27, 2024, show positive signs of growth in key financial metrics, suggesting improved financial performance and contributing to the positive performance of its stock on that day.

Tags: LRCX
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Biotechnology Markets and money

Bearish Sentiment Dominates Options Market for Super Micro Computer SMCI

Analysts Bullish on Rhythm Pharmaceuticals Growth Potential

Finance_Fiscal (2)

Goldman Sachs Analyst Maintains Neutral Rating for Seagate Technology Holdings with Increased Price Target

Recommended

Nio Stock

Nio Shares Approach Annual Peak on Strong Delivery Performance

9 months ago
Chinook Therapeutics Stock

Former Chinook Director Denies Insider Trading Allegations

10 months ago
Protalix Biotherapeutics Stock

Protalix Biotherapeutics Approaches Pivotal Catalysts

5 months ago
Artesian Stock

Artesian Executive’s Stock Sale Raises Questions Among Investors

10 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Netflix Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Take-Two Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics XRP
No Result
View All Result

Highlights

Knowledge Exodus and Tech Failures Threaten Germany’s Workforce as Priorities Shift

Wendy’s Shares Rocket as Reddit Traders and New Management Collide

SpaceX Stock Edges Higher as Starfall Debut and Starlink Launch Reinforce Operational Momentum

Kratos Defense: Record Backlog Meets Insider Sales and a Cease-Fire

Kontron’s Share Price Stalls at €23.40 as Takeover Cap and Edge AI Hype Collide

IBM Scores Analyst Upgrades and White House Quantum Backing, but Consulting Weakness Clouds the Outlook

Trending

Nel ASA Stock
Analysis

Nel ASA’s Washington State Deal Offers Rare Bright Spot as Stock Hovers at Decisive Level

by Kennethcix
June 24, 2026
0

The Douglas County Public Utility District in Washington State doesn’t typically make headlines in the hydrogen sector....

Micron Stock

Micron’s $20 Billion Balancing Act: Can HBM4 Outrun the Memory Market’s Boom-Bust Cycle?

June 24, 2026
Rocket Lab USA Stock

Rocket Lab’s Operational Wins Can’t Shield Stock From SpaceX Bond and Nasdaq Fallout

June 24, 2026
FALLBACK Stock

Knowledge Exodus and Tech Failures Threaten Germany’s Workforce as Priorities Shift

June 24, 2026
Wendy's Stock

Wendy’s Shares Rocket as Reddit Traders and New Management Collide

June 24, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Nel ASA’s Washington State Deal Offers Rare Bright Spot as Stock Hovers at Decisive Level
  • Micron’s $20 Billion Balancing Act: Can HBM4 Outrun the Memory Market’s Boom-Bust Cycle?
  • Rocket Lab’s Operational Wins Can’t Shield Stock From SpaceX Bond and Nasdaq Fallout

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com